Green fluorescent protein as a reporter of human µ-opioid receptor overexpression and localization in the methylotrophic yeast Pichia pastoris

Journal of Biotechnology

Volumn 99, Issue 1, 2002, Pages 23-39

  Sarramegna, Valérie ^a   Talmont, Franck ^a   Seree de Roch, Marc ^a   Milon, Alain ^a   Demange, Pascal ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

GFP; GPCR; Heterologous expression; Membrane protein; Pichia pastoris

Indexed keywords

CELL MEMBRANES; ELECTRON MICROSCOPY; FLUORESCENCE; YEAST;

FLUORESCENCE INTENSITY ANALYSIS;

PROTEINS;

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; BETA FUNALTREXAMINE; BINALTORPHIMINE; GREEN FLUORESCENT PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; ICI 174486; MU OPIATE RECEPTOR; NALOXONE; NICOTINAMIDE ADENINE DINUCLEOTIDE;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FLUORESCENCE; GENE LOCATION; GENE OVEREXPRESSION; METHYLOTROPHIC BACTERIUM; MOLECULAR BIOLOGY; NONHUMAN; PICHIA PASTORIS; PRIORITY JOURNAL; PROMOTER REGION; YEAST;

GENE EXPRESSION; GENE EXPRESSION REGULATION, FUNGAL; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MEMBRANE PROTEINS; PICHIA; RECEPTORS, OPIOID, MU; SENSITIVITY AND SPECIFICITY;

PICHIA; PICHIA PASTORIS;

EID: 0037048801     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1656(02)00161-X     Document Type: Article

References (44)

1. Albano C.R., Randers-Eichhorn L., et al. Green fluorescent protein as a real time quantitative reporter of heterologous protein production. Biotechnol. Prog. 14:(2):1998;351-354.
2. Ausubel F.M., Brent R., et al. Current Protocols in Molecular Biology. 1989;John Wiley and Sons, NY.
3. Barak L.S., Ferguson S.S., et al. Internal trafficking and surface mobility of a functionally intact beta2-adrenergic receptor-green fluorescent protein conjugate. Mol. Pharmacol. 51:(2):1997;177-184.
4. Bikker J.A., Trumpp-Kallmeyer S., et al. G-protein coupled receptors: models, mutagenesis, and drug design. J. Med. Chem. 41:(16):1998;2911-2927.
5. Chen Y., Mestek A., et al. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol. Pharmacol. 44:(1):1993;8-12.
6. Cregg J.M., Vedvick T.S., et al. Recent advances in the expression of foreign genes in Pichia pastoris. Biotechnology (NY). 11:(8):1993;905-910.
7. Criado M., Eibl H., et al. Effects of lipids on acetylcholine receptor. Essential need of cholesterol for maintenance of agonist-induced state transitions in lipid vesicles. Biochemistry. 21:(15):1982;3622-3629.
8. Ficca A.G., Testa L., et al. The human beta 2-adrenergic receptor expressed in Schizosaccharomyces pombe retains its pharmacological properties. FEBS Lett. 377:(2):1995;140-144.
9. Frances B., Moisand C., et al. Na+ ions and Gpp(NH)p selectively inhibit agonist interactions at mu- and kappa-opioid receptor sites in rabbit and guinea-pig cerebellum membranes. Eur. J. Pharmacol. 117:(2):1985;223-232.
10. Fuentes J.M., Lompré A.M., Moller J.V., Falson P., Le Maire M. Clean western blots of membrane proteins after yeast heterologous expression following a shortened version of the method of Perini et al. Anal. Biochem. 285:2000;276-278.
11. Gaibelet G., Capeyrou R., et al. Identification in the mu-opioid receptor of cysteine residues responsible for inactivation of ligand binding by thiol alkylating and reducing agents. FEBS Lett. 408:(2):1997;135-140.
12. Gimpl G., Fahrenholz F. Human oxytocin receptors in cholesterol-rich vs. cholesterol-poor microdomains of the plasma membrane. Eur. J. Biochem. 267:(9):2000;2483-2497.
13. Gimpl G., Klein U., et al. Expression of the human oxytocin receptor in baculovirus-infected insect cells: high-affinity binding is induced by a cholesterol-cyclodextrin complex. Biochemistry. 34:(42):1995;13794-13801.
14. Hasegawa J., Loh H.H., et al. Lipid requirement for mu opioid receptor binding. J. Neurochem. 49:(4):1987;1007-1012.
15. Huang H.J., Liao C.F., et al. Functional expression of rat M5 muscarinic acetylcholine receptor in yeast. Biochem. Biophys. Res. Commun. 182:(3):1992;1180-1186.
16. Kiefer H., Krieger J., Olszewski J.D., Von Heijne G., Prestwich G.D., Breer H. Expression of an olfactory receptor in Escherichia coli: purification, reconstitution, and ligand binding. Biochemistry. 35:1996;16077-16084.
17. King K., Dohlman H.G., et al. Control of yeast mating signal transduction by a mammalian beta 2-adrenergic receptor and Gs alpha subunit [published erratum appears in Science 1991 Jan 11;251(4990):144]. Science. 250:(4977):1990;121-123.
18. Kirilovsky J., Eimerl S., et al. Function of the delipidated beta-adrenergic receptor appears to require a fatty acid or a neutral lipid in addition to phospholipids. Eur. J. Biochem. 166:(1):1987;221-228.
19. Kruckeberg A.L., Ye L., et al. Functional expression, quantification and cellular localization of the Hxt2 hexose transporter of Saccharomyces cerevisiae tagged with the green fluorescent protein. Biochem. J. 339:(Pt 2):1999;299-307.
20. Lagane B., Gaibelet G., et al. Role of sterols in modulating the human micro-opioid receptor function in Saccharomyces cerevisiae [In Process Citation]. J. Biol. Chem. 275:(43):2000;33197-33200.
21. Lowry O.H. J. Biol. Chem. 193:1951;265-276.
22. Luecke H., Schobert B., et al. Structure of bacteriorhodopsin at 1.55 A resolution. J. Mol. Biol. 291:(4):1999;899-911.
23. Massou S., Puech V., et al. Heterologous expression of a deuterated membrane-integrated receptor and partial deuteration in methylotrophic yeasts. J. Biomol. NMR. 14:(3):1999;231-239.
24. Meilhoc E., Masson J.M., et al. High efficiency transformation of intact yeast cells by electric field pulses [published erratum appears in Biotechnology (NY) 1990 Aug;8(8):768]. Biotechnology (NY). 8:(3):1990;223-227.
25. Mestek A., Hurley J.H., et al. The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J. Neurosci. 15:(3 Pt 2):1995;2396-2406.
26. Nunez M.T., Glass J. Reconstitution of the transferrin receptor in lipid vesicles. Effect of cholesterol on the binding of transferrin. Biochemistry. 21:(17):1982;4139-4143.
27. Palczewski K., Kumasaka T., et al. Crystal structure of rhodopsin: A G protein-coupled receptor [see comments]. Science. 289:(5480):2000;739-745.
28. Payette P., Gossard F., et al. Expression and pharmacological characterization of the human M1 muscarinic receptor in Saccharomyces cerevisiae. FEBS Lett. 266:(1-2):1990;21-25.
29. Raynor K., Kong H., et al. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol. Pharmacol. 45:(2):1994;330-334.
30. Raynor K., Kong H., et al. Characterization of the cloned human mu opioid receptor. J. Pharmacol. Exp. Ther. 272:(1):1995;423-428.
31. Romanos M.A., Scorer C.A., et al. Foreign gene expression in yeast: a review. Yeast. 8:(6):1992;423-488.
32. Sander P., Grunewald S., et al. Constitutive expression of the human D2S-dopamine receptor in the unicellular yeast Saccharomyces cerevisiae. Biochim. Biophys. Acta. 1193:(2):1994;255-262.
33. Sander P., Grunewald S., et al. Expression of the human D2S dopamine receptor in the yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe: a comparative study. FEBS Lett. 344:(1):1994;41-46.
34. Scorer C.A., Clare J.J., et al. Rapid selection using G418 of high copy number transformants of Pichia pastoris for high-level foreign gene expression. Biotechnology (NY). 12:(2):1994;181-184.
35. Soulie S., Moller J.V., et al. Urea reduces the aggregation of membrane proteins on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal. Biochem. 236:(2):1996;363-364.
36. Stadel J.M., Wilson S., et al. Orphan G protein-coupled receptors: a neglected opportunity for pioneer drug discovery. Trends Pharmacol. Sci. 18:(11):1997;430-437.
37. Stanasila L., Pattus F., et al. Heterologous expression of G-protein-coupled receptors: human opioid receptors under scrutiny. Biochimie. 80:(5-6):1998;563-571.
38. Talmont F., Sidobre S., et al. Expression and pharmacological characterization of the human mu-opioid receptor in the methylotrophic yeast Pichia pastoris. FEBS Lett. 394:(3):1996;268-272.
39. Tarasova N.I., Stauber R.H., et al. Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type A. J. Biol. Chem. 272:(23):1997;14817-17824.
40. Tsien R.Y. The green fluorescent protein. Annu. Rev. Biochem. 67:1998;509-544.
41. Weiss H.M., Haase W., et al. Expression of functional mouse 5-HT5A serotonin receptor in the methylotrophic yeast Pichia pastoris: pharmacological characterization and localization. FEBS Lett. 377:(3):1995;451-456.
42. Weiss H.M., Haase W., et al. Comparative biochemical and pharmacological characterization of the mouse 5HT5A 5-hydroxytryptamine receptor and the human beta2-adrenergic receptor produced in the methylotrophic yeast Pichia pastoris. Biochem. J. 330:(Pt 3):1998;1137-1147.
43. Weiss H.M., Haase W., et al. Expression of an integral membrane protein, the 5HT5A receptor. Methods Mol. Biol. 103:1998;227-239.
44. Xue J.C., Chen C., et al. Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor. J. Biol. Chem. 269:(48):1994;30195-30199.